EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2818.20. On previous day, the ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Alector has completed subject enrolment in the 76-week, randomised, Phase II PROGRESS-AD trial, which is assessing the ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...